Olfactory bulbectomy results in a marked increase in gonadotropin secretion and prevents the reproductive regression associated with short photoperiod when the olfactory bulbectomy is done before exposure to the inhibitory photoperiod. The present study tested whether olfactory bulbectomy would offset the influence of short photoperiod if done after the reproductive system had regressed. Adult golden hamsters Mesocricetus auratus were divided into four groups: early sham (surgery at week-4); early olfactory bulbectomy (surgery at week-4); late sham (surgery at week 14) and late olfactory bulbectomy (surgery at week 14). At t = 0, all golden hamsters were placed in a short photoperiod (L:D 10:14). Early olfactory bulbectomy prevented testicular regression; the late olfactory bulbectomy group recrudesced much earlier than the sham groups. These results indicate that the tonic inhibitory influence of the olfactory bulbs is required for initiation of short photoperiod induced testicular regression and is also essential for the maintenance of the regressed state.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0304-3940(93)90714-v | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic citalopram effects on the brain neurochemical profile and perfusion in a rat model of depression detected by the NMR techniques - spectroscopy and perfusion.
Biomed Pharmacother
December 2024
Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address:
Background: Major depressive disorder (MDD) is a mental illness with a high worldwide prevalence and suboptimal pharmacological treatment, which necessitates the development of novel, more efficacious MDD medication. Nuclear magnetic resonance (NMR) can non-invasively provide insight into the neurochemical state of the brain using proton magnetic resonance spectroscopy (H MRS), and an assessment of regional cerebral blood flow (rCBF) by perfusion imaging. These methods may provide valuable in vivo markers of the pathological processes underlying MDD.
View Article and Find Full Text PDFEmpagliflozin ameliorates olfactory bulbectomy-induced depression by mitigating oxidative stress and possible involvement of brain derived neurotrophic factor in diabetic rats.
Int J Neurosci
October 2024
Department of Pharmacology, Rajarshi Shahu College of Pharmacy, Buldana, India.
Article Synopsis
- Empagliflozin, an SGLT2 inhibitor, was tested for its antidepressant effects in diabetic rats using a model that simulates neuroinflammation-mediated depression after performing olfactory bulbectomy (OBX) surgery.
- The study involved treating the rats with oral doses of empagliflozin, metformin, and clomipramine over 14 days, and measuring changes in behavior and antioxidant levels.
- Results indicated that empagliflozin improved depressive behaviors and restored antioxidant levels in the brain, suggesting it may help treat depression linked to neuroinflammation and oxidative stress.
A Mouse Model of Sporadic Alzheimer's Disease with Elements of Major Depression.
Mol Neurobiol
July 2024
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
After olfactory bulbectomy, animals are often used as a model of major depression or sporadic Alzheimer's disease and, hence, the status of this model is still disputable. To elucidate the nature of alterations in the expression of the genome after the operation, we analyzed transcriptomes of the cortex, hippocampus, and cerebellum of the olfactory bulbectomized (OBX) mice. Analysis of the functional significance of genes in the brain of OBX mice indicates that the balance of the GABA/glutamatergic systems is disturbed with hyperactivation of the latter in the hippocampus, leading to the development of excitotoxicity and induction of apoptosis in the background of severe mitochondrial dysfunction and astrogliosis.
View Article and Find Full Text PDFRepeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice.
Pharmaceuticals (Basel)
June 2024
Department of Human Physiology, Institute of Medical Sciences, Medical College of Rzeszow University, Kopisto 2a, 35-959 Rzeszow, Poland.
Growing evidence suggests that activators of nuclear factor erythroid-derived 2-like 2 (Nrf2), such as sulforaphane, may represent promising novel pharmacological targets for conditions related to oxidative stress, including depressive disorder. Therefore, we conducted a study to explore the behavioral and biochemical effects of repeated (14 days) sulforaphane (SFN) treatment in the olfactory bulbectomy (OB) animal model of depression. An open field test (OFT), splash test (ST), and spontaneous locomotor activity test (LA) were used to assess changes in depressive-like behavior and the potential antidepressant-like activity of SFN.
View Article and Find Full Text PDFOlfactory genes affect major depression in highly educated, emotionally stable, lean women: a bridge between animal models and precision medicine.
Transl Psychiatry
April 2024
Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
Most current approaches to establish subgroups of depressed patients for precision medicine aim to rely on biomarkers that require highly specialized assessment. Our present aim was to stratify participants of the UK Biobank cohort based on three readily measurable common independent risk factors, and to investigate depression genomics in each group to discover common and separate biological etiology. Two-step cluster analysis was run separately in males (n = 149,879) and females (n = 174,572), with neuroticism (a tendency to experience negative emotions), body fat percentage, and years spent in education as input variables.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!